DCT
2:15-cv-01455
Allergan Inc v. Teva Pharma USA Inc
General
Filed
08/24/15
Cause of ActionInfringement
SectorBiotech
Status
Closed (12/13/18)
Patent Owner
Operating Company (L)
PACER
2:15-cv-01455
Appeals
CourtE.D. Texas
Judge | Period | PO Win Rate |
|---|---|---|
12/22/15 - 03/13/19 | 25% | |
08/27/15 - 12/22/15 | 32% |
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L5 E | |
L4 A | |
L3 A | |
L3 A | |
L2 D | |
L1 C | |
-- -- -- | |
L5 E | |
L5 A | |
L5 D | |
L5 E | |
L5 E | |
L2 E | |
L5 E | |
L4 E |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L2 C |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L4 C | |
L2 E | |
L1 B | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
Gillam & Smith LLPLocal | L5 A |
L5 A | |
L5 A | |
Potter MintonLocal | L5 A |
L5 A | |
L5 B | |
-- -- -- | |
L4 B | |
L5 A | |
L4 B | |
L4 E | |
-- -- -- | |
L3 C | |
L4 A | |
L4 E | |
L3 C | |
L2 C | |
-- -- -- | |
L3 E | |
L2 D | |
L2 E | |
L2 C | |
L2 B | |
L2 D | |
L5 B | |
L5 B | |
-- -- -- | |
L2 E | |
L2 A | |
L2 B | |
-- -- -- | |
-- -- -- | |
L2 E | |
L4 E | |
L3 D | |
L2 E | |
-- -- -- | |
L1 E | |
-- -- -- |
No Attorneys